Finance 12 February 2026

Salesforce Stock Near 52-Week Low as AI Fears Drown Out Agentforce Growth

Salesforce Stock Near 52-Week Low as AI Fears Drown Out Agentforce Growth

Salesforce shares fell 4.1% to $169.15 midday Thursday, nearing a 52-week low, as software stocks declined despite the company’s record quarterly revenue and expanded buyback. The drop followed news that Anthropic restricted access to its AI model after finding cybersecurity flaws, fueling concerns about software vulnerability. Salesforce’s fiscal 2027 revenue forecast missed Wall Street’s midpoint estimates.
April 9, 2026
DraftKings stock sinks after weak 2026 forecast as prediction-markets spend takes focus

DraftKings stock sinks after weak 2026 forecast as prediction-markets spend takes focus

DraftKings shares dropped 13% in after-hours trading Thursday after its 2026 revenue and profit outlook missed Wall Street estimates. The company reported fourth-quarter revenue up 43% to $1.99 billion and posted positive net income for 2025. Monthly unique payers were flat at 4.8 million. DraftKings cited increased investment in its Predictions product ahead of 2026 launches.
February 12, 2026
Coinbase posts $667 million loss as crypto rout drags revenue down — and the Q1 clue traders seized on

Coinbase posts $667 million loss as crypto rout drags revenue down — and the Q1 clue traders seized on

Coinbase posted a $667 million fourth-quarter loss as net revenue fell 22% to $1.71 billion, missing analyst estimates. Transaction revenue dropped to $983 million, driven by a sharp fall in consumer activity after a late-2025 crypto selloff. Subscription and services revenue climbed 13% to $727 million, boosted by stablecoins. Shares fell about 8% after the report.
February 12, 2026
Rivian stock lifts on R2 launch timeline, but 2026 outlook points to more losses

Rivian stock lifts on R2 launch timeline, but 2026 outlook points to more losses

Rivian forecast 2026 deliveries of 62,000 to 67,000 vehicles, up from 42,247 in 2025, as it prepares to launch the R2 SUV in the second quarter. The company posted $1.29 billion in fourth-quarter revenue and $120 million in gross profit, but reported a net loss of $804 million. Rivian guided to an adjusted EBITDA loss of $1.8 billion to $2.1 billion and capital spending up to $2.05 billion this year.
February 12, 2026
Merck (MRK) stock swings, ends flat after FDA clears Keytruda regimen in ovarian cancer

Merck (MRK) stock swings, ends flat after FDA clears Keytruda regimen in ovarian cancer

Merck shares closed down 0.03% at $119.28 after the FDA approved a Keytruda-based regimen for certain platinum-resistant ovarian cancer patients. The stock had reached $121.62 earlier in the session. Merck also announced new bladder and kidney cancer data to be presented at ASCO GU later this month. Chief Marketing Officer Chirfi Guindo sold 10,000 shares at an average price of $121.46.
February 12, 2026
AST SpaceMobile stock slides 16% after $1 billion convertible notes, share sale plan grabs the tape

AST SpaceMobile stock slides 16% after $1 billion convertible notes, share sale plan grabs the tape

AST SpaceMobile shares fell 16% to $81.14 in after-hours trading Thursday after the company announced a $1 billion convertible note offering tied to its satellite buildout. Trading volume topped 27 million shares. AST reported $2.78 billion in year-end cash and preliminary 2025 revenue of $63–71 million. The new notes are set to settle Feb. 17, with related transactions expected around Feb. 20.
February 12, 2026
Wells Fargo stock drops again as WFC slides with banks ahead of Friday CPI

Wells Fargo stock drops again as WFC slides with banks ahead of Friday CPI

Wells Fargo shares fell 2.7% to $86.53 Thursday afternoon, underperforming U.S. financial stocks ahead of Friday’s inflation data. The Financial Select Sector SPDR Fund dropped 1.5%, while the S&P 500 ETF slipped 1.2%. Investors adjusted bets on Federal Reserve rate cuts after a strong jobs report. Wells Fargo management cited loan growth in cards and autos, with credit performance holding steady.
February 12, 2026
Accenture stock price slides nearly 4% as CEO share sale, AI jitters weigh on ACN

Accenture stock price slides nearly 4% as CEO share sale, AI jitters weigh on ACN

Accenture shares fell 3.8% to $221.58 Thursday after touching $215.22 intraday, with about 7.5 million shares traded. CEO Julie Sweet disclosed a planned sale of 6,057 shares in an SEC filing. Traders are watching the March 19 earnings call and a May 20 GAO deadline on a $1.4 billion federal contract protest. Peers IBM, Cognizant, DXC, and Infosys also declined.
February 12, 2026
Boston Scientific stock edges higher as Wall Street slides — what’s next for BSX shares

Boston Scientific stock edges higher as Wall Street slides — what’s next for BSX shares

Boston Scientific shares rose 1.2% to $74.38 Thursday, outperforming a 1% drop in U.S. indexes as tech stocks sold off ahead of Friday’s CPI report. The stock remains volatile after a 17% plunge last week, triggered by weaker-than-expected electrophysiology sales and a slower 2026 growth forecast. CEO Michael Mahoney recently sold shares under a pre-set plan. Stryker and Medtronic shares also gained in Thursday trading.
February 12, 2026
GE Aerospace stock swings as Reuters reports CFM weighs “Plan B” engine design

GE Aerospace stock swings as Reuters reports CFM weighs “Plan B” engine design

GE Aerospace shares rose 0.3% to $314.60 in Thursday afternoon trading after a Reuters report said CFM International, its joint venture with Safran, is considering a backup design for its next engine. CFM is weighing both an “open-fan” and a more conventional “advanced ducted” concept for future Boeing and Airbus jets. Investors are watching Safran’s Feb. 13 results for signals on LEAP engine production and service demand.
February 12, 2026
Citigroup stock tumbles as banks slide ahead of CPI, rate-cap noise returns

Citigroup stock tumbles as banks slide ahead of CPI, rate-cap noise returns

Citigroup shares dropped 4.2% to $112.45 in Thursday afternoon trading, extending losses as U.S. bank stocks slid ahead of Friday’s CPI data. Incoming CFO Gonzalo Luchetti warned a proposed credit-card rate cap could cut credit access for lower-income borrowers. JPMorgan, Bank of America, and Wells Fargo also fell. Investors cited rate expectations and political scrutiny of card pricing.
February 12, 2026
Thermo Fisher stock slides 4%: Datavant data pact and $3.8B notes put TMO in focus

Thermo Fisher stock slides 4%: Datavant data pact and $3.8B notes put TMO in focus

Thermo Fisher shares fell 4.3% to $504.53 Thursday afternoon, extending a recent slide. The company expects to settle a $3.8 billion debt offering on Feb. 12 to help fund its pending Clario acquisition. Thermo Fisher also announced a data collaboration with Datavant. An executive vice president sold 400 shares under a pre-set plan, according to an SEC filing.
February 12, 2026
Chevron stock slips as oil drops; Venezuela block report and Libya entry come into focus

Chevron stock slips as oil drops; Venezuela block report and Libya entry come into focus

Chevron shares fell 1.4% to $183.25 as oil prices dropped sharply after the IEA flagged weaker demand and rising supply. Exxon Mobil and BP U.S. shares also declined, tracking crude. Chevron was named winning bidder for Libya’s Sirte S4 exploration license, pending a production-sharing agreement. Venezuela may grant Chevron and Repsol new oil blocks this week, according to Bloomberg sources.
February 12, 2026
AbbVie stock jumps as Botox Medicare lawsuit puts Washington back in focus

AbbVie stock jumps as Botox Medicare lawsuit puts Washington back in focus

AbbVie shares rose nearly 3% after the company sued U.S. health agencies to block Medicare price controls for Botox. The lawsuit argues Botox should be exempt from the Inflation Reduction Act’s negotiation program as a plasma-derived product. Investors are watching for early court developments and the Medicare timeline for 2028 prices. The case was assigned to U.S. District Judge Carl Nichols.
February 12, 2026
CoreWeave stock price flips higher after a 5% dip as AI nerves hit tech

CoreWeave stock price flips higher after a 5% dip as AI nerves hit tech

CoreWeave shares rose 0.2% to $95.36 after swinging between $90.38 and $97.67, with 15.3 million shares traded. SEC filings showed insider selling, including a proposed 50,000-share sale under Rule 144 and trades by Chief Development Officer Brannin McBee under a 10b5-1 plan. Broader tech stocks fell. Investors await Friday’s U.S. inflation data and CoreWeave’s earnings on Feb. 26.
February 12, 2026
1 125 126 127 128 129 139